| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An EMT-like signature as a potential driver of myeloid sarcoma
|
Zorn, Kristin E.
|
|
|
1 |
3 |
p.
|
artikel
|
| 2 |
Augmented use of L-asparaginase markedly improves AYA ALL outcomes: FBMTG prospective MRD2014 study
|
Nagafuji, Koji
|
|
|
1 |
3 |
p.
|
artikel
|
| 3 |
Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system
|
Jiang, Jun Y.
|
|
|
1 |
3 |
p.
|
artikel
|
| 4 |
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study
|
DeZern, Amy E.
|
|
|
1 |
3 |
p.
|
artikel
|
| 5 |
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia
|
Simoes, Catia
|
|
|
1 |
3 |
p.
|
artikel
|
| 6 |
Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation
|
Dekker, Linde
|
|
|
1 |
3 |
p.
|
artikel
|
| 7 |
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
|
Choudhry, Priya
|
|
|
1 |
3 |
p.
|
artikel
|
| 8 |
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice
|
Timofeeva, Natalia
|
|
|
1 |
3 |
p.
|
artikel
|
| 9 |
Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation
|
Ghosh, Nilanjan
|
|
|
1 |
3 |
p.
|
artikel
|
| 10 |
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level
|
Jann, Johann-Christoph
|
|
|
1 |
3 |
p.
|
artikel
|
| 11 |
Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma
|
Strouse, Christopher S.
|
|
|
1 |
3 |
p.
|
artikel
|
| 12 |
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
|
Kemps, Paul G.
|
|
|
1 |
3 |
p.
|
artikel
|
| 13 |
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
|
Othman, Jad
|
|
|
1 |
3 |
p.
|
artikel
|
| 14 |
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
|
Dührsen, Ulrich
|
|
|
1 |
3 |
p.
|
artikel
|
| 15 |
T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
|
Kroeze, Emma
|
|
|
1 |
3 |
p.
|
artikel
|
Tijdschrift beschrijving